Regarding the STMN1 gene, studies have shown that STMN1 is a biomarker for diagnosing microvascular infiltration, may be a potential therapeutic target for inhibiting HCC metastasis, and is also involved in the regulation of immune infiltration and M6A methylation in HCC (31). The gene discussed is STMN1; the disease is hepatocellular carcinoma.